异甘草酸镁联合恩替卡韦治疗慢性乙型肝炎肝硬化的疗效观察OA
Observation on the efficacy of magnesium isoglycyrrhizinate combined with entecavir in the treatment of chronic hepatitis B cirrhosis
目的 探讨异甘草酸镁联合恩替卡韦治疗慢性乙型肝炎肝硬化的临床疗效.方法 选择2021年1月至2024年3月医院收治的78例慢性乙型肝炎肝硬化患者,以随机方法分组,每组39例.对照组采用恩替卡韦治疗,观察组在此基础上结合异甘草酸镁治疗.对两组临床疗效、肝功能与肝纤维化指标、不良反应进行比较.结果 观察组治疗总疗效率高于对照组,P＜0.05.治疗后观察组AST、ALT、TBIL、HA、PC-Ⅲ、LN、Ⅳ-C均较对照组低,P＜0.05.观察组不良反应发…查看全部>>
Objective:To Objective To explore the clinical efficacy of magnesium isoglycyrrhizinate combined with entecavir in the treatment of chronic hepatitis B cirrhosis.Methods:78 patients with chronic hepatitis B cirrhosis ad-mitted to the hospital from January 2021 to March 2024 were randomly divided into two groups,with 39 cases in each group.The control group was treated with entecavir,and the observation group was treated with magnesium isoglycyrrhizinate on t…查看全部>>
高静;杨红梅;周德
盐城市亭湖区人民医院传染科,江苏盐城 224000盐城市亭湖区人民医院传染科,江苏盐城 224000盐城市亭湖区人民医院传染科,江苏盐城 224000
临床医学
异甘草酸镁恩替卡韦慢性乙型肝炎肝硬化不良反应
Magnesium isoglycyrrhizinateEntecavirChronic hepatitis BLiver cirrhosiAdverse reactions
《生命科学仪器》 2024 (2)
125-127,3
评论